NSW government seizes $1m of illegal e-cigarette products in 19 weeks

Events
Jun.13.2022

Cancer Council commends ‘zero tolerance’ for unlawful sales

 

Cancer Council NSW has commended the NSW Government’s “zero tolerance” of nicotine e-cigarette sales without a doctor’s prescription, following a major increase in the volume of illegal products seized in 2022 compared with the past two years.

 

Director of Cancer Prevention and Advocacy at Cancer Council NSW, Anita Dessaix, said the surge in illegal product seizures comes only six weeks after Australian National University (ANU) published a landmark study highlighting the extensive harms of e-cigarettes especially to young people.

 

“In the 18 months from July 2020 to the end of last year, $2 million worth of illegal nicotine e-cigarette products was seized – and the government has since seized half as much again in only 19 weeks this year,” Ms Dessaix said.

 

As it stands, the only legal way to access a vape containing nicotine is via a valid doctor’s prescription for those who feel it will aid their quit smoking journey. However, illegal seizure trends are growing exponentially,

 

“We see unlawful e-cigarette use everywhere we look, with young people the main users. Community concern among parents and teachers in particular is rising..

 

“The recently published ANU report showed that the majority of e-cigarette users are young, they are not using e-cigarettes to quit smoking, they are using e-cigarettes with, not instead of, tobacco and those who don’t smoke face a three-fold risk of smoking uptake.

“We congratulate the NSW Government for warning retailers selling e-cigarettes without a valid prescription that they could face fines and even jail for contributing to this crisis.

 

“For the sake of a profit, these merchants are addicting young people to nicotine, they are exposing young people to a three-fold risk of smoking uptake, and they are flouting federal and state laws designed to protect public health.

 

“NSW Government, and its Chief Health Officer, Dr Kerry Chant, have shown great leadership in highlighting the major harms of e-cigarettes and putting the merchants who are contributing to it on notice.”

 

“This is about ensuring that vaping doesn’t undo decades of public health efforts to prevent harm caused by tobacco products”.

Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
Imperial Brands Explains What the UK Tobacco and Vapes Act 2026 Means for Retailers
Imperial Brands Explains What the UK Tobacco and Vapes Act 2026 Means for Retailers
Imperial Brands has outlined what the newly approved UK Tobacco and Vapes Act 2026 means for retailers. The legislation received Royal Assent on April 29, 2026, and gives the Government powers to extend tobacco-style regulation to a wider range of products, including vaping products, heated tobacco, nicotine pouches and cigarette papers. Imperial Brands emphasized that most measures will be introduced in phases rather than taking effect immediately.
May.11 by 2FIRSTS.ai
American Snuff Expands Manufacturing Hiring as Reynolds American Builds Future-Ready Operations
American Snuff Expands Manufacturing Hiring as Reynolds American Builds Future-Ready Operations
Reynolds American said American Snuff Company will add more than 50 manufacturing roles at its Clarksville, Tennessee facility as part of its wider U.S. manufacturing investment plan. The company said the hiring is one of the latest developments under its plan to invest more than USD 3.2 billion across U.S. operations by 2030.
Mar.27 by 2FIRSTS.ai
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai
Netherlands Plans Law to Ban Possession of Large Quantities of Vapes Intended for Trade
Netherlands Plans Law to Ban Possession of Large Quantities of Vapes Intended for Trade
Dutch Health Minister Hermans is drafting legislation that would also ban possession of larger quantities of vapes, allowing the Netherlands Food and Consumer Product Safety Authority to intervene earlier and seize stock before proving that trade has taken place.
Apr.13 by 2FIRSTS.ai
Shunhao Shares Reports 2025 Revenue of RMB 1.188 Billion, While Q1 2026 Net Profit Rises 49.94% and New Tobacco Operations Continue
Shunhao Shares Reports 2025 Revenue of RMB 1.188 Billion, While Q1 2026 Net Profit Rises 49.94% and New Tobacco Operations Continue
Shunhao Shares’ 2025 annual report summary and first-quarter 2026 report show that the company recorded 2025 revenue of RMB 1.188 billion, down 21.78% year on year, while net profit attributable to shareholders rose 30.00% to RMB 58.94 million. In the first quarter of 2026, revenue was RMB 291.51 million, down 10.34% year on year, while attributable net profit rose 49.94% to RMB 19.98 million.
Apr.29 by 2FIRSTS.ai